New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
16:02 EDTBIODBiodel: FDA grants orphan drug designation for Glucagon
Biodel announced that the FDA has granted orphan drug designation for Biodel's 'glucagon' for the prevention of hypoglycemia in the congenital hyperinsulinism population. The FDA grants orphan designation to promote development of therapies to treat rare diseases. Once this designation is granted, the sponsor may be eligible for a range of incentives including FDA grant funding for clinical trial costs, tax credits related to development expenses, waiver of FDA user fees, and a seven-year period of marketing exclusivity in the U.S. following FDA approval.
News For BIOD From The Last 14 Days
Check below for free stories on BIOD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
16:02 EDTBIODBiodel names Gary Gemignani as CFO
Biodel Inc (BIOD) announced that Gary Gemignani has been appointed as the company's CFO, effective September 15. Gemignani was most recently with Champions Oncology (CSBR) where he served as CFO and executive VP with responsibility for raising capital, investor relations and all financial operations.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use